Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10485008 | Value in Health | 2014 | 8 Pages |
Abstract
Under uncertainty and irreversibility, low-risk patients must begin the second-line treatment as soon as possible, which is precisely when the second-line treatment is least valuable. As the costs of reversing current treatment impacts fall, it becomes more feasible to provide the option-preserving treatment to these low-risk individuals later on.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Felipa PhD,